 HIV antigen variability ARC/AIDS natural variability human immunodeficiency virus antigen HIV Ag time untreated HIV-infected patients percentage change serum HIV Ag antigenemic ARC/AIDS subjects placebo week clinical trial month observation differences HIV Ag change month observation periods monthly changes median subject mean monthly HIV Ag change change standard deviation increase decrease HIV Ag changes lengths observation months possible pairwise combinations HIV Ag levels T-cell changes whole study HIV Ag changes period Knowledge broad HIV Ag variability useful sample size categorical responses unlikely clinical trials antiviral agents HIV Ag changes surrogate markers efficacy